Type 2 diabetes, PUFAs, and vitamin D: their relation to inflammation
AL Guadarrama-López… - Journal of …, 2014 - Wiley Online Library
Chronic diseases have become one of the most important public health problems, due to
their high costs for treatment and prevention. Until now, researchers have considered that …
their high costs for treatment and prevention. Until now, researchers have considered that …
Secretomics for skeletal muscle cells: a discovery of novel regulators?
Metabolic tissues, including skeletal muscle, adipose tissue and the digestive system,
dynamically secrete various factors depending on the metabolic state, communicate with …
dynamically secrete various factors depending on the metabolic state, communicate with …
Anti-inflammatory and pro-inflammatory adipokine profiles in children on vegetarian and omnivorous diets
J Ambroszkiewicz, M Chełchowska, G Rowicka… - Nutrients, 2018 - mdpi.com
Adipose tissue is a highly active endocrine organ that secrets many pro-inflammatory as well
anti-inflammatory adipokines. The aim of the study was to assess serum adipokine profile in …
anti-inflammatory adipokines. The aim of the study was to assess serum adipokine profile in …
Peripheral CB1 receptor neutral antagonist, AM6545, ameliorates hypometabolic obesity and improves adipokine secretion in monosodium glutamate induced obese …
H Ma, G Zhang, C Mou, X Fu, Y Chen - Frontiers in pharmacology, 2018 - frontiersin.org
Effect of peripheral cannabinoid receptor 1 (CB1R) blockade by AM6545 in the monosodium
glutamate (MSG)-induced hypometabolic and hypothalamic obesity was observed, and the …
glutamate (MSG)-induced hypometabolic and hypothalamic obesity was observed, and the …
Serum 25-Hydroxyvitamin D Levels, phosphoprotein enriched in diabetes gene product (PED/PEA-15) and leptin-to-adiponectin ratio in women with PCOS
Background Polycystic ovary syndrome (PCOS) is frequently associated with
hypovitaminosis D. Vitamin D is endowed with pleiotropic effects, including insulin …
hypovitaminosis D. Vitamin D is endowed with pleiotropic effects, including insulin …
Retinol binding protein 4 affects the adipogenesis of porcine preadipocytes through insulin signaling pathways
J Cheng, ZY Song, L Pu, H Yang… - … and Cell Biology, 2013 - cdnsciencepub.com
Retinol binding protein 4 (RBP4), a novel cytokine, is mainly secreted by hepatocytes and
adipocytes. RBP4 reportedly induces insulin resistance and RBP4 secretion is increased in …
adipocytes. RBP4 reportedly induces insulin resistance and RBP4 secretion is increased in …
LH-21, A peripheral cannabinoid receptor 1 antagonist, exerts favorable metabolic modulation including antihypertensive effect in KKAy mice by regulating …
Z Dong, H Gong, Y Chen, H Wu, J Wu… - Frontiers in …, 2018 - frontiersin.org
Patients with obesity are susceptible to hypertension and diabetes. Over-activation of
cannabinoid receptor 1 (CB1R) in adipose tissue is proposed in the pathophysiology of …
cannabinoid receptor 1 (CB1R) in adipose tissue is proposed in the pathophysiology of …
Novel therapeutic intervention of coenzyme Q10 and its combination with pioglitazone on the mRNA expression level of adipocytokines in diabetic rats
Aims Aim of the present study was to investigate the effect of co-administration coenzyme
Q10 and pioglitazone on the mRNA expression of adipocytokines in white adipose tissues of …
Q10 and pioglitazone on the mRNA expression of adipocytokines in white adipose tissues of …
CTSB promotes porcine preadipocytes differentiation by degrading fibronectin and attenuating the Wnt/β-catenin signaling pathway
ZY Zhang, Y Mai, H Yang, PY Dong, XL Zheng… - Molecular and Cellular …, 2014 - Springer
The process of preadipocytes differentiation plays a vital role in adipose tissue expansion
and many factors are involved in this event. Cathepsin B (CTSB), secreted from lysosome …
and many factors are involved in this event. Cathepsin B (CTSB), secreted from lysosome …
[HTML][HTML] Intervention effects of atorvastatin combined with Panax notoginseng saponins on rats with atherosclerosis complicated with hepatic injury
QF Jiang, MY Huang, KY Wu, JL Weng… - Pharmacognosy …, 2017 - ncbi.nlm.nih.gov
Background: Statins cannot be used for some active liver diseases, which limits its
application to some extent. The combined use of statins with other drugs may be one of the …
application to some extent. The combined use of statins with other drugs may be one of the …